in vitro News and Research

RSS

DNA Script successfully synthesizes world's first 150-nucleotide strand of DNA

DNA Script, the global leader in the development of enzymatic DNA synthesis, today announced that it has successfully synthesized the world's first 150-nucleotide strand of DNA by de novo enzymatic synthesis.

3 Oct 2018

Study identifies camelid nanobodies capable of blocking EGF in cancer cells

The natural world often provides the answer to unsolved medical problems. On this occasion, the solution to a challenge posed by cancer has come about from the immune system of camelids.

3 Oct 2018

New study offers infertile women information on expected probabilities of becoming pregnant

A new Journal of Obstetrics and Gynaecology Research study offers infertile women new information regarding their expected probabilities of becoming pregnant and may help them select the optimal treatment based on their various risk factors.

3 Oct 2018

Researchers for the first time differentiate human inner ear cells in laboratory

Researchers from the University of Bern and Bern University Hospital have managed for the first time to differentiate human inner ear cells in a laboratory from somatic progenitors and to investigate their origin.

3 Oct 2018

Single ovary removal for fertility preservation in girls causes no complications

In the first publication from the U.S. on surgical techniques and outcomes of single ovary removal for fertility preservation in girls, surgeons from Ann & Robert H. Lurie Children's Hospital of Chicago report that the procedure caused no complications and can be performed laparoscopically, on an outpatient basis, without delaying treatment for cancer or other therapies posing high risk of infertility.

1 Oct 2018

TEAD1 protein appears to be important regulator of tumor migration in glioblastoma

A specific protein called TEAD1 is an important regulator of tumor migration in glioblastoma, the most common brain tumor in adults, and deactivating this protein may stop tumor cells from migrating away from the main tumor mass, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 1 in the journal Nature Communications.

1 Oct 2018

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Today the U.S. Food and Drug Administration permitted marketing of ClonoSEQ assay, a next generation sequencing-based test for minimal residual disease in patients with acute lymphoblastic leukemiaor multiple myeloma. MRD is a measure of the amount of cancer cells remaining in a person's bone marrow.

30 Sep 2018

Researchers decipher antitumor mechanism of Amazonian plant in human cancer cells

A piece of research conducted by the Free Radicals and Oxidative Stress Group at the UPV/EHU's Faculty of Medicine and Nursing has deciphered the antitumor mechanism exerted by the plant Vismia baccifera, originally from the Amazonian region of Colombia, in human liver cancer cells.

28 Sep 2018

Axol's Human iPSC-derived Microglia for neuroimmunology research

Our Human iPSC-derived Microglia are suitable for a variety of applications including in vitro disease models, phenotypic screening and immunology studies.

From Axol Bioscience Ltd 27 Sep 2018

Crown Bioscience announces successful validation of well-characterized prostate cancer PDX models

Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, has announced the addition of unique, well characterized, fully annotated patient-derived xenograft models of prostate cancer.

27 Sep 2018

Yellow fever virus can be transmitted via tiger mosquitoes, shows research

Since December 2016, Brazil has been grappling with its worst yellow fever outbreak for several decades. To date, there have been 2,043 human cases including 676 fatalities, mainly occurring in ten Brazilian states including Rio de Janeiro and São Paulo.

26 Sep 2018

Researchers develop promising allergy vaccine for hay fever

Using sugar molecules researchers from the University of Copenhagen have developed a new vaccine for hay fever that may reduce treatment times and increase the effect of treatments.

26 Sep 2018

RTI Surgical showcases innovative spine portfolio at NASS 2018

RTI Surgical, Inc., a global surgical implant company, will showcase research reinforcing the strength of its spine portfolio, notably the Fortilink IBF series featuring TETRAfuse 3D Technology, at the North American Spine Society's 33rd Annual Meeting in Los Angeles, September 26-29.

26 Sep 2018

in vitro News and Research

DNA Script successfully synthesizes world's first 150-nucleotide strand of DNA

Study identifies camelid nanobodies capable of blocking EGF in cancer cells

New study offers infertile women information on expected probabilities of becoming pregnant

Researchers for the first time differentiate human inner ear cells in laboratory

Single ovary removal for fertility preservation in girls causes no complications

TEAD1 protein appears to be important regulator of tumor migration in glioblastoma

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Researchers decipher antitumor mechanism of Amazonian plant in human cancer cells

Axol's Human iPSC-derived Microglia for neuroimmunology research

Crown Bioscience announces successful validation of well-characterized prostate cancer PDX models

Yellow fever virus can be transmitted via tiger mosquitoes, shows research

Researchers develop promising allergy vaccine for hay fever

RTI Surgical showcases innovative spine portfolio at NASS 2018

Exploring parallels between biological and computing world

Researchers find molecule that halts, reverts neurodegeneration caused by Parkinson's disease

Hybrid theranostic complex shows high therapeutic efficacy against tumor cells

Researchers highlight potential therapy for treating rare, deadly blood-clotting disorder

Researchers develop technology to study behavior of implants without animal testing

Study reveals promising new drug candidate to treat acute renal failure

Innovative approach for developing vaccine against most prevalent human malaria parasite

Driving innovation in drug discovery with in vitro biology solutions eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News